N-methyl-N-(1-(2-((1-methyl-1H-pyrazol-5-yl)amino)benzoyl)piperidin-4-yl)-4-trifluoromethyl-benzamide

ID: ALA4641704

PubChem CID: 156016449

Max Phase: Preclinical

Molecular Formula: C25H26F3N5O2

Molecular Weight: 485.51

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C(=O)c1ccc(C(F)(F)F)cc1)C1CCN(C(=O)c2ccccc2Nc2ccnn2C)CC1

Standard InChI:  InChI=1S/C25H26F3N5O2/c1-31(23(34)17-7-9-18(10-8-17)25(26,27)28)19-12-15-33(16-13-19)24(35)20-5-3-4-6-21(20)30-22-11-14-29-32(22)2/h3-11,14,19,30H,12-13,15-16H2,1-2H3

Standard InChI Key:  AWSDDUNNGCDAHC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    4.4285  -10.7652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2439  -10.7664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6508  -10.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2434   -9.3558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4249   -9.3586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0217  -10.0637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0200  -11.4731    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2028  -11.4732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6519  -11.4744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2428  -12.1818    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4691  -11.4751    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8735  -12.1845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6871  -12.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1001  -11.4816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6933  -10.7717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8735  -10.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7192  -10.8148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9420  -11.0675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9422  -11.8847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7195  -12.1369    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9717  -12.9142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9173  -11.4853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3227  -12.1949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3291  -10.7795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9108  -12.9007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1398  -12.1986    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0957  -12.8941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6840  -13.5991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0894  -14.3096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9108  -14.3108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3188  -13.6052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6785  -15.0160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8613  -15.0134    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.0848  -15.7250    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.2639  -15.7206    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  2  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  8 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20  8  1  0
 20 21  1  0
 14 22  1  0
 22 23  1  0
 22 24  1  0
 23 25  1  0
 23 26  2  0
 25 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 25  1  0
 29 32  1  0
 32 33  1  0
 32 34  1  0
 32 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4641704

    ---

Associated Targets(Human)

SMO Tclin Smoothened homolog (1371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 485.51Molecular Weight (Monoisotopic): 485.2039AlogP: 4.56#Rotatable Bonds: 5
Polar Surface Area: 70.47Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.26CX LogP: 4.51CX LogD: 4.51
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.58Np Likeness Score: -1.90

References

1. Ji D, Zhang W, Xu Y, Zhang JJ..  (2020)  Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors.,  28  (6): [PMID:32063403] [10.1016/j.bmc.2020.115354]

Source